Short, Animated Storytelling (SAS) Videos to Reduce Smartphone Addiction in the US (SAS)
Short, Animated Storytelling Videos to Reduce Smartphone Addiction in the US: Protocol for an Online, Randomized Controlled Trial
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
California
-
Stanford, California, United States, 94305
- Stanford University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- English Speaking
- Own a Smartphone
- Live in the US
Exclusion Criteria:
- None
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Active Comparator: Informational Control
Participants will read a fact sheet containing written information and statistics about smartphone usage.
|
A short fact sheet presenting written information and statistics about smartphone usage.
|
|
No Intervention: Do-nothing control
Participants will only complete the surveys.
Participants do not receive any intervention or information about digital addiction.
|
|
|
Experimental: Animated videos
Participants will watch two short, animated storytelling videos about digital addiction.
|
The short animated videos (approximately 2 minutes each) draw attention to the dangers of smartphone addiction.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Smartphone Addiction Scale (SmAS) score
Time Frame: Baseline, 2 weeks and 4 weeks post intervention
|
SmAS is a short 10 item validated scale measuring smartphone addiction.
The minimum value is 10 and the maximum value is 60 for this scale.
|
Baseline, 2 weeks and 4 weeks post intervention
|
|
Mobile Phone Attachment Scale - Anxious Attachment Sub Scale (MPAS-AA)
Time Frame: Baseline, immediate post-intervention (up to 24 hours), 2 weeks and 4 weeks post intervention
|
The MPAS Anxious Attachment subscale comprises 7 items rated 1 (not at all true) to 5 (extremely true).
Subscale scores were computed as the mean of the 7 items (range 1-5), with higher scores indicating greater anxious attachment to one's mobile phone.
The MPAS-AA has demonstrated good internal consistency (α=.87) and external validity.
|
Baseline, immediate post-intervention (up to 24 hours), 2 weeks and 4 weeks post intervention
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Mobile Phone Attachment Scale - Addiction Sub Scale (MPAS_Addiction)
Time Frame: Baseline, 2 weeks and 4 weeks post intervention
|
Mobile phone addiction will be assessed with the MPAS Addiction subscale (6 items).
Items are rated on a 5-point scale from 1 = not at all true to 5 = extremely true; responses are averaged to create a subscale score (range 1-5), with higher scores indicating greater addictive/problematic mobile phone use.
|
Baseline, 2 weeks and 4 weeks post intervention
|
|
Perceived Danger of Smartphone Overuse measured using a visual analogue scale (VAS)
Time Frame: Baseline, immediately post intervention exposure (up to 24 hours), 2 weeks and 4 weeks post intervention exposure
|
Perceived danger of smartphone overuse will be assessed with a single-item 10-point slider (visual analogue-type scale) ranging from 0 = not at all dangerous to 10 = extremely dangerous.
Higher scores indicate greater perceived danger.
|
Baseline, immediately post intervention exposure (up to 24 hours), 2 weeks and 4 weeks post intervention exposure
|
|
Self-reported daily smartphone use (past 2 weeks)
Time Frame: Baseline, 2 weeks and 4 weeks post intervention exposure
|
Self-reported daily smartphone use will be assessed via a single self-report item asking participants: 'On average, how many hours per day did you use your phone over the past two weeks?' Responses are recorded in 6 ordered categories: <1 h, 1-2 h, 2-4 h, 4-6 h, 6-8 h, >8 h, with higher categories indicating greater daily use.
|
Baseline, 2 weeks and 4 weeks post intervention exposure
|
|
Self-perceived smartphone addiction (single item; Olsen)
Time Frame: Baseline, immediately post intervention exposure (up to 24 hours) 2 weeks and 4 weeks post intervention exposure
|
Self-perceived smartphone addiction will be assessed using Olsen's single-item smartphone addiction measure, asking agreement with the statement 'I am addicted to my smartphone' on a 6-point Likert scale from Strongly disagree (1) to Strongly agree (6).
Higher scores indicate greater self-perceived smartphone addiction.
|
Baseline, immediately post intervention exposure (up to 24 hours) 2 weeks and 4 weeks post intervention exposure
|
Collaborators and Investigators
Sponsor
Sponsor
Investigators
Investigators
- Principal Investigator: Maya U Adam, MD, Stanford University
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 80171
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.